AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
KSH: in April, retail turnover exceeded the same period of the previous year by 5.0 percent and the previous month by 2.0 percent
In April 2025, the volume of retail trade turnover increased…
Read more >FAO food price index fell in May
The benchmark global food price index fell in May from…
Read more >Eurozone retail sales rise in April
Retail sales in the eurozone and the European Union increased…
Read more >